Ana Cristina Torres-Pérez

Ana Cristina Torres-Pérez

Auto-generated profile, based on publicly available information

Ana Cristina Torres-Pérez

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Geriatrics Gerontology and Aging
Verified
Journal Article
Closed access
ANAna Patricia Navarrete-Reyes
Ana Patricia Navarrete-Reyes
JNJuan Pablo Negrete-Najar
Juan Pablo Negrete-Najar
GCGabriel Cojuc-Konigsberg
Gabriel Cojuc-Konigsberg
JGJimena Gómez-Camacho
Jimena Gómez-Camacho
YJYoselin Juárez-Carrillo
Yoselin Juárez-Carrillo
YCYanin Chavarri-Guerra
Yanin Chavarri-Guerra
Cancer is a disease of older adults, with 60% of cancer diagnoses and 70% of cancer deaths occurring in individuals ≥ 65 years. Normal oral aging may transition to disease in the presence of one or more potential modifiers, such as a new oncological diagnosis or a new treatment. Oral conditions in patients with cancer cause significant morbidity. Previous work suggests that oral conditions are neither elicited/assessed/reassessed nor well-managed or investigated in older patients. However, frequently reported oral conditions in patients undergoing cancer therapy include xerostomia, dysgeusia, candidiasis, mucositis, and dental caries. Some oncological treatments such as hematopoietic stem cell transplant or chemotherapy/radiotherapy for head and neck cancers entail higher risks of oral complications. No specific recommendations in the case of older adults with cancer-associated oral conditions are available. Treatment recommendations are based on low levels of evidence and/or evidence extrapolated from younger patients with câncer.

21 March 2026 in The Lancet Healthy Longevity
Verified
Journal Article
Open access
PDPauline Duquenne
Pauline Duquenne
GLGabor Liposits
Gabor Liposits
CVCassandra O Vonnes
Cassandra O Vonnes
ENErna Navarrete
Erna Navarrete
AGAdolfo González-Serrano
Adolfo González-Serrano
SPSophie Pilleron
Sophie Pilleron
Mortality risk prediction models can support decision making in older adults with cancer; however, existing models are associated with a high risk of bias. This systematic review assessed published prediction models for overall and all-cause mortality in adults with cancer aged 65 years or older. We searched for publications in Ovid Embase, Ovid Medline, Cochrane CENTRAL, and EBSCO CINAHL on Nov 25, 2022, and updated the search on Feb 24, 2024. We included 250 studies, of which 182 (72·8%) reported both model development and internal validation. 176 (70·4%) of 250 models predicted overall survival; 40 (16·0%) models focused on lung cancer and 30 (12·0%) models on colorectal cancer. 43 (17·2%) models were specifically developed for older adults; 138 (55·2%) models did not incorporate geriatric variables such as comorbidities, nutrition, and cognition. Risk of bias was high in all models, largely owing to inappropriate handling of continuous predictors, univariable selection of predictors, and inadequate control for overfitting. These limitations preclude clinical use. Future models predicting overall and all-cause mortality in older adults with cancer should adhere to existing methodological guidelines and incorporate geriatric domains.

5 January 2025 in Internal and Emergency Medicine
Verified
Journal Article
Closed access
PDF file
CGCarolina Gómez-Moreno
Carolina Gómez-Moreno
ACAlan Alexis Chacón-Corral
Alan Alexis Chacón-Corral
APAyari Pérez-Méndez
Ayari Pérez-Méndez
Ashuin Kammar-GarcíaAshuin Kammar-García
Ashuin Kammar-García
COCorina Ortega-Ortiz
Corina Ortega-Ortiz
THThierry Hernandez-Gilsoul
Thierry Hernandez-Gilsoul

1 January 2021 in Geriatrics Gerontology and Aging
Verified
Journal Article
Closed access
ANAna Patricia Navarrete-Reyes
Ana Patricia Navarrete-Reyes
KAKarla Animas-Mijangos
Karla Animas-Mijangos
JGJimena Gómez-Camacho
Jimena Gómez-Camacho
YJYoselin Juárez-Carrillo
Yoselin Juárez-Carrillo
ATAna Cristina Torres-Pérez
Ana Cristina Torres-Pérez
ESEnrique Soto-Pérez-De-Celis
Enrique Soto-Pérez-De-Celis
Cancer is primarily a disease of older persons. Given the heterogeneity of aging, physiological age, rather than chronological age, better expresses the cumulative effect of environmental, medical, and psychosocial stressors, which modifies life expectancy. Comprehensive geriatric assessment, a tool that helps ascertain the physiological age of older individuals, is the gold standard for assessing older adults with cancer. Several international organizations recommend using the geriatric assessment domains to identify unrecognized health problems that can interfere with treatment and predict adverse health-related outcomes, aiding complex treatment decision making. More recently, it has been shown that geriatric assessment-guided interventions improve quality of life and mitigate treatment toxicity without compromising survival. In this review, we discuss the role of comprehensive geriatric assessment in cancer care for older adults and provide the reader with useful information to assess potential treatment risks and benefits, anticipate complications, and plan interventions to better care for older people with cancer.